{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:04:45Z","timestamp":1793271885166,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project established by Chinese Pharmaceutical Association Hospital Pharmacy department","award":["CPA-Z05-ZC-2023002"],"award-info":[{"award-number":["CPA-Z05-ZC-2023002"]}]},{"name":"the Youth Fund of the National Natural Science Foundation of China","award":["8230082561"],"award-info":[{"award-number":["8230082561"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07127-1","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T13:13:46Z","timestamp":1751894026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety profile of ramelteon from the perspective of physicians and pharmacists: a 20-year real-world pharmacovigilance analysis based on the FAERS database"],"prefix":"10.1186","volume":"25","author":[{"given":"Jianhong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghe","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"7","key":"7127_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2013.193","volume":"309","author":"DJ Buysse","year":"2013","unstructured":"Buysse DJ. Insomnia Jama. 2013;309(7):706\u201316.","journal-title":"Insomnia Jama"},{"issue":"1","key":"7127_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JAD-215324","volume":"86","author":"R Benca","year":"2022","unstructured":"Benca R, Herring WJ, Khandker R, Qureshi ZP. Burden of insomnia and sleep disturbances and the impact of sleep treatments in patients with probable or possible alzheimer\u2019s disease: A structured literature review. J Alzheimer\u2019s Disease: JAD. 2022;86(1):83\u2013109.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"7127_CR3","doi-asserted-by":"publisher","first-page":"15026","DOI":"10.1038\/nrdp.2015.26","volume":"1","author":"CM Morin","year":"2015","unstructured":"Morin CM, Drake CL, Harvey AG, Krystal AD, Manber R, Riemann D, Spiegelhalder K. Insomnia disorder. Nat Reviews Disease Primers. 2015;1:15026.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"7127_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s13311-021-01010-z","volume":"18","author":"S Madari","year":"2021","unstructured":"Madari S, Golebiowski R, Mansukhani MP, Kolla BP. Pharmacological management of insomnia. Neurotherapeutics: J Am Soc Experimental Neurother. 2021;18(1):44\u201352.","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"},{"issue":"6","key":"7127_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s12325-009-0041-6","volume":"26","author":"SR Pandi-Perumal","year":"2009","unstructured":"Pandi-Perumal SR, Srinivasan V, Spence DW, Moscovitch A, Hardeland R, Brown GM, Cardinali DP. Ramelteon: a review of its therapeutic potential in sleep disorders. Adv Therapy. 2009;26(6):613\u201326.","journal-title":"Adv Therapy"},{"issue":"4","key":"7127_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.smrv.2007.12.005","volume":"12","author":"MJ Sateia","year":"2008","unstructured":"Sateia MJ, Kirby-Long P, Taylor JL. Efficacy and clinical safety of ramelteon: an evidence-based review. Sleep Med Rev. 2008;12(4):319\u201332.","journal-title":"Sleep Med Rev"},{"issue":"6","key":"7127_CR7","doi-asserted-by":"publisher","first-page":"e13939","DOI":"10.1111\/jsr.13939","volume":"32","author":"J Maruani","year":"2023","unstructured":"Maruani J, Reynaud E, Chambe J, Palagini L, Bourgin P, Geoffroy PA. Efficacy of melatonin and Ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and meta-analysis. J Sleep Res. 2023;32(6):e13939.","journal-title":"J Sleep Res"},{"key":"7127_CR8","doi-asserted-by":"publisher","first-page":"111345","DOI":"10.1016\/j.jpsychores.2023.111345","volume":"170","author":"J Beaucage-Charron","year":"2023","unstructured":"Beaucage-Charron J, Rinfret J, Coveney R, Williamson D. Melatonin and Ramelteon for the treatment of delirium: A systematic review and meta-analysis. J Psychosom Res. 2023;170:111345.","journal-title":"J Psychosom Res"},{"issue":"3","key":"7127_CR9","doi-asserted-by":"publisher","first-page":"e12857","DOI":"10.1111\/jpi.12857","volume":"74","author":"CL Yu","year":"2023","unstructured":"Yu CL, Carvalho AF, Thompson T, Tsai TC, Tseng PT, Tu YK, Yang SN, Yang FC, Chang CH, Hsu CW, et al. Ramelteon for delirium prevention in hospitalized patients: an updated meta-analysis and trial sequential analysis of randomized controlled trials. J Pineal Res. 2023;74(3):e12857.","journal-title":"J Pineal Res"},{"issue":"12","key":"7127_CR10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2165\/00023210-200519120-00007","volume":"19","author":"A McGechan","year":"2005","unstructured":"McGechan A, Wellington K, Ramelteon. CNS Drugs. 2005;19(12):1057\u201365. discussion 1066\u2013\u20091057.","journal-title":"CNS Drugs"},{"issue":"3","key":"7127_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5665\/sleep\/32.3.351","volume":"32","author":"G Mayer","year":"2009","unstructured":"Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M. Efficacy and safety of 6-month nightly Ramelteon administration in adults with chronic primary insomnia. Sleep. 2009;32(3):351\u201360.","journal-title":"Sleep"},{"key":"7127_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajp.2015.09.004","volume":"18","author":"C Shah","year":"2015","unstructured":"Shah C, Kablinger A. Ramelteon-induced nightmares: A case report. Asian J Psychiatry. 2015;18:111\u20132.","journal-title":"Asian J Psychiatry"},{"key":"7127_CR13","doi-asserted-by":"publisher","first-page":"894685","DOI":"10.3389\/fphar.2022.894685","volume":"13","author":"Z Feng","year":"2022","unstructured":"Feng Z, Li X, Tong WK, He Q, Zhu X, Xiang X, Tang Z. Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS. Front Pharmacol. 2022;13:894685.","journal-title":"Front Pharmacol"},{"key":"7127_CR14","doi-asserted-by":"crossref","unstructured":"Wu J, Li N, Gu J, Shen Y, Qiu L, Zhu L. Post-marketing safety evaluation of vortioxetine: A decade-long pharmacovigilance study based on the FAERS database. J Affect Disord . 2025;379:586\u201393.","DOI":"10.1016\/j.jad.2025.03.007"},{"issue":"1","key":"7127_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12888-024-05813-0","volume":"24","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Qu Y, Du Z, Ou M, Shen Y, Zhou Q, Tian L, Zhu H. Exploring adverse events of vilazodone: evidence from the FAERS database. BMC Psychiatry. 2024;24(1):371.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"7127_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.therap.2022.10.002","volume":"78","author":"C Lacroix","year":"2023","unstructured":"Lacroix C, Maurier A, Largeau B, Destere A, Thillard EM, Drici M, Micallef J, Jonville-Bera AP. Sex differences in adverse drug reactions: are women more impacted? Therapie. 2023;78(2):175\u201388.","journal-title":"Therapie"},{"issue":"1","key":"7127_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chest.2018.04.005","volume":"154","author":"MF Pengo","year":"2018","unstructured":"Pengo MF, Won CH, Bourjeily G. Sleep in women across the life span. Chest. 2018;154(1):196\u2013206.","journal-title":"Chest"},{"key":"7127_CR18","doi-asserted-by":"publisher","first-page":"e46538","DOI":"10.2196\/46538","volume":"10","author":"BHP Lau","year":"2024","unstructured":"Lau BHP, Tang CSK, Holroyd E, Wong WCW. Challenges and implications for menopausal health and Help-Seeking behaviors in midlife women from the united States and China in light of the COVID-19 pandemic: Web-Based panel surveys. JMIR Public Health Surveillance. 2024;10:e46538.","journal-title":"JMIR Public Health Surveillance"},{"issue":"1","key":"7127_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1755-5949.2008.00066.x","volume":"15","author":"M Miyamoto","year":"2009","unstructured":"Miyamoto M. Pharmacology of ramelteon, a selective MT1\/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS Neurosci Ther. 2009;15(1):32\u201351.","journal-title":"CNS Neurosci Ther"},{"key":"7127_CR20","doi-asserted-by":"publisher","first-page":"114681","DOI":"10.1016\/j.biopha.2023.114681","volume":"162","author":"D Schetz","year":"2023","unstructured":"Schetz D, Scott TE, Waldman W, Sein Anand J, Wiergowski M, Koci\u0107 I. Reports analysis of psychotropic drugs related adverse reactions in Australia and Poland during the COVID 19 pandemic. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2023;162:114681.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"Suppl 19","key":"7127_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12859-018-2520-8","volume":"19","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Peng H, Zhang X, Zhao Z, Yin J, Li J. Predicting adverse drug reactions of combined medication from heterogeneous Pharmacologic databases. BMC Bioinformatics. 2018;19(Suppl 19):517.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"7127_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40264-014-0150-2","volume":"37","author":"KB Hoffman","year":"2014","unstructured":"Hoffman KB, Dimbil M, Erdman CB, Tatonetti NP, Overstreet BM. The Weber effect and the united States food and drug administration\u2019s adverse event reporting system (FAERS): analysis of sixty-two drugs approved from 2006 to 2010. Drug Saf. 2014;37(4):283\u201394.","journal-title":"Drug Saf"},{"issue":"8","key":"7127_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1124\/dmd.110.034009","volume":"38","author":"RS Obach","year":"2010","unstructured":"Obach RS, Ryder TF. Metabolism of Ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on Ramelteon pharmacokinetics. Drug Metab Dispos. 2010;38(8):1381\u201391.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"7127_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s13311-021-01011-y","volume":"18","author":"M Irfan","year":"2021","unstructured":"Irfan M, Schenck CH, Howell MJ. NonREM disorders of arousal and related parasomnias: an updated review. Neurotherapeutics: J Am Soc Experimental Neurother. 2021;18(1):124\u201339.","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"},{"issue":"1","key":"7127_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jphs.2020.11.006","volume":"145","author":"A Yoshimoto","year":"2021","unstructured":"Yoshimoto A, Yamashiro K, Suzuki T, Ikegaya Y, Matsumoto N. Ramelteon modulates gamma oscillations in the rat primary motor cortex during non-REM sleep. J Pharmacol Sci. 2021;145(1):97\u2013104.","journal-title":"J Pharmacol Sci"},{"key":"7127_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.conb.2017.07.009","volume":"46","author":"F Weber","year":"2017","unstructured":"Weber F. Modeling the mammalian sleep cycle. Curr Opin Neurobiol. 2017;46:68\u201375.","journal-title":"Curr Opin Neurobiol"},{"issue":"8","key":"7127_CR27","doi-asserted-by":"publisher","first-page":"E273","DOI":"10.1503\/cmaj.120808","volume":"186","author":"JA Fleetham","year":"2014","unstructured":"Fleetham JA, Fleming JA, Parasomnias. CMAJ: Can Med Association J = J De l\u2019Association Medicale Canadienne. 2014;186(8):E273\u2013280.","journal-title":"CMAJ: Can Med Association J = J De l\u2019Association Medicale Canadienne"},{"key":"7127_CR28","first-page":"73","volume":"8","author":"A Horv\u00e1th","year":"2016","unstructured":"Horv\u00e1th A, Papp A, Sz\u0171cs A. Progress in elucidating the pathophysiological basis of nonrapid eye movement parasomnias: not yet informing therapeutic strategies. Nat Sci Sleep. 2016;8:73\u20139.","journal-title":"Nat Sci Sleep"},{"issue":"5\u201306","key":"7127_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.18071\/isz.75.0171","volume":"75","author":"A Sz\u00fbcs","year":"2022","unstructured":"Sz\u00fbcs A, Mutti C, Papp A, Hal\u00e1sz P, Parrino L. REM sleep, REM parasomnias, REM sleep behaviour disorder. Ideggyogyaszati Sz. 2022;75(5\u201306):171\u201382.","journal-title":"Ideggyogyaszati Sz"},{"issue":"2D Half","key":"7127_CR30","first-page":"167","volume":"109","author":"JB Murray","year":"1984","unstructured":"Murray JB. Effects of valium and librium on human psychomotor and cognitive functions. Genetic Psychol Monogr. 1984;109(2D Half):167\u201397.","journal-title":"Genetic Psychol Monogr"},{"issue":"4","key":"7127_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.pnpbp.2011.03.013","volume":"35","author":"V Srinivasan","year":"2011","unstructured":"Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Prog Neuro-psychopharmacol Biol Psychiatry. 2011;35(4):913\u201323.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"3","key":"7127_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/fcp.12745","volume":"36","author":"J Baudot","year":"2022","unstructured":"Baudot J, Soeiro T, Tambon M, Navarro N, Veyrac G, Mezaache S, Micallef J. Safety concerns on the abuse potential of esketamine: multidimensional analysis of a new anti-depressive drug on the market. Fundam Clin Pharmacol. 2022;36(3):572\u201381.","journal-title":"Fundam Clin Pharmacol"},{"key":"7127_CR33","doi-asserted-by":"publisher","first-page":"j745","DOI":"10.1136\/bmj.j745","volume":"356","author":"EC Hunter","year":"2017","unstructured":"Hunter EC, Charlton J, David AS. Depersonalisation and derealisation: assessment and management. BMJ (Clinical Res ed). 2017;356:j745.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"4","key":"7127_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0031-9384(99)00204-8","volume":"68","author":"LA Brotto","year":"2000","unstructured":"Brotto LA, Gorzalka BB. Melatonin enhances sexual behavior in the male rat. Physiol Behav. 2000;68(4):483\u20136.","journal-title":"Physiol Behav"},{"issue":"15","key":"7127_CR35","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2174\/09298673113209990114","volume":"20","author":"L Shi","year":"2013","unstructured":"Shi L, Li N, Bo L, Xu Z. Melatonin and hypothalamic-pituitary-gonadal axis. Curr Med Chem. 2013;20(15):2017\u201331.","journal-title":"Curr Med Chem"},{"issue":"1","key":"7127_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/07853899808999391","volume":"30","author":"RJ Reiter","year":"1998","unstructured":"Reiter RJ. Melatonin and human reproduction. Ann Med. 1998;30(1):103\u20138.","journal-title":"Ann Med"},{"issue":"6","key":"7127_CR37","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2214\/ajr.175.6.1751557","volume":"175","author":"LF Donnelly","year":"2000","unstructured":"Donnelly LF, Strife JL, Myer CM 3. Glossoptosis (posterior displacement of the tongue) during sleep: a frequent cause of sleep apnea in pediatric patients referred for dynamic sleep fluoroscopy. AJR Am J Roentgenol. 2000;175(6):1557\u201360.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"7127_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1600-079X.2011.00871.x","volume":"51","author":"Y Hibaoui","year":"2011","unstructured":"Hibaoui Y, Reutenauer-Patte J, Patthey-Vuadens O, Ruegg UT, Dorchies OM. Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy. J Pineal Res. 2011;51(2):163\u201371.","journal-title":"J Pineal Res"},{"issue":"11","key":"7127_CR39","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","volume":"17","author":"C Trenkwalder","year":"2018","unstructured":"Trenkwalder C, Allen R, H\u00f6gl B, Clemens S, Patton S, Schormair B, Winkelmann J. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 2018;17(11):994\u20131005.","journal-title":"Lancet Neurol"},{"issue":"6","key":"7127_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1023\/A:1015187601628","volume":"21","author":"N Zisapel","year":"2001","unstructured":"Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol. 2001;21(6):605\u201316.","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"7127_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/practneurol-2019-002460","volume":"20","author":"J Virdee","year":"2020","unstructured":"Virdee J, Mollan SP, Photopsia. Pract Neurol. 2020;20(5):415\u20139.","journal-title":"Pract Neurol"},{"key":"7127_CR42","doi-asserted-by":"publisher","first-page":"100798","DOI":"10.1016\/j.preteyeres.2019.100798","volume":"75","author":"HA Alkozi","year":"2020","unstructured":"Alkozi HA, Navarro G, Franco R, Pintor J. Melatonin and the control of intraocular pressure. Prog Retin Eye Res. 2020;75:100798.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"7127_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.preteyeres.2007.10.001","volume":"27","author":"AF Wiechmann","year":"2008","unstructured":"Wiechmann AF, Summers JA. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues. Prog Retin Eye Res. 2008;27(2):137\u201360.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"7127_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0042-6989(89)90057-6","volume":"29","author":"S Reuss","year":"1989","unstructured":"Reuss S, Kiefer W. Melatonin administered systemically alters the properties of visual cortex cells in cat: further evidence for a role in visual information processing. Vision Res. 1989;29(9):1089\u201393.","journal-title":"Vision Res"},{"issue":"4","key":"7127_CR45","doi-asserted-by":"publisher","first-page":"103238","DOI":"10.1016\/j.dsx.2025.103238","volume":"19","author":"R Di Stefano","year":"2025","unstructured":"Di Stefano R, Rindi LV, Baldini V, Rossi R, Pacitti F, Jannini EA, Rossi A. Glucagon-Like Peptide-1 receptor agonists, dual GIP\/GLP-1 receptor agonist Tirzepatide and suicidal ideation and behavior: A systematic review of clinical studies and pharmacovigilance reports. Diabetes Metabolic Syndrome. 2025;19(4):103238.","journal-title":"Diabetes Metabolic Syndrome"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07127-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:03:49Z","timestamp":1751897029000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07127-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7127"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07127-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was based on data from the publicly available FAERS database. All data were de-identified and contained no personally identifiable information or patient interventions. Therefore, ethical approval and informed consent were not required in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"683"}}